Tender detail
Conclusion of non-exclusive discount agreements for medicines containing nilotinib under an open-house model
Summary
The tender concerns the conclusion of non-exclusive discount agreements for medicines containing the active substance nilotinib under an open-house model. Any interested pharmaceutical company may participate if it meets the participation requirements and accepts the contract terms. There is no exclusivity and no individual contract negotiations. The exact submission documents, deadlines and proof requirements must be checked in the tender documents.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.